57 results
Page 2 of 3
425
x0x zzktoupsqv48e
5 May 21
Business combination disclosure
5:26pm
425
bfprj79j988j8k
5 May 21
Business combination disclosure
5:24pm
6-K
EX-99.1
74hseajf6hro fxcx
5 May 21
Agreement and Plan of Merger
5:19pm
6-K
EX-99.5
ivr s9wbce6va6jz4
5 May 21
Agreement and Plan of Merger
5:19pm
6-K
EX-99.1
lgdz b629ix
5 May 21
Amryt Pharma to Acquire Chiasma, Inc. to Further Strengthen Global Leadership in Rare and Orphan Diseases
8:45am
20-F
gvlcisbsugvpxw77ih1z
30 Apr 21
Annual report (foreign)
12:53pm
20-F
EX-2.7
jhla s8crz6sszkm1z3
30 Apr 21
Annual report (foreign)
12:53pm
424B3
xagqu5d1k2 3z0g30
4 Mar 21
Prospectus supplement
8:38am
6-K
EX-99.1
3y2 hpj4bccxp7w
4 Mar 21
Amryt Announces Record FY 2020 Results
8:20am
424B4
qzaqjzwsu
14 Jan 21
Prospectus supplement with pricing info
9:30am
F-1/A
bo29we7s
12 Jan 21
Registration statement (foreign) (amended)
12:00am
F-1
ecjzlw0bw8d bpvzja
8 Jan 21
Registration statement (foreign)
4:58pm
DRS
3b0lznhgxhxxiuvug
18 Dec 20
Draft registration statement
12:00am
6-K
s8kxb6p5guhl0z
9 Dec 20
Current report (foreign)
4:23pm
6-K
EX-99.1
83fwg vxzx4ycxo3f
9 Dec 20
Amryt Group Receives Marketing Authorisation Approval for Lojuxta® in Brazil
6:30am
6-K
EX-99.1
q3n m65x92g9cpop2dw
8 Dec 20
Amryt Announces $40m Private Placement with Leading Biotech Investors
6:05am
6-K
EX-99.1
c98 1t7eqbf6l
3 Nov 20
Current report (foreign)
8:45am
424B4
pyi1ty2
8 Jul 20
Prospectus supplement with pricing info
4:05pm
F-1/A
o7zmqx
7 Jul 20
Registration statement (foreign) (amended)
5:02pm
F-1/A
17gopsd
6 Jul 20
Registration statement (foreign) (amended)
5:28pm